收费全文 | 102249篇 |
免费 | 4327篇 |
国内免费 | 228篇 |
耳鼻咽喉 | 1490篇 |
儿科学 | 3088篇 |
妇产科学 | 2673篇 |
基础医学 | 13811篇 |
口腔科学 | 3024篇 |
临床医学 | 6149篇 |
内科学 | 23649篇 |
皮肤病学 | 2844篇 |
神经病学 | 7917篇 |
特种医学 | 2228篇 |
外国民族医学 | 2篇 |
外科学 | 13037篇 |
综合类 | 478篇 |
一般理论 | 26篇 |
预防医学 | 11342篇 |
眼科学 | 2322篇 |
药学 | 7575篇 |
中国医学 | 330篇 |
肿瘤学 | 4819篇 |
2023年 | 567篇 |
2022年 | 345篇 |
2021年 | 1726篇 |
2020年 | 894篇 |
2019年 | 1984篇 |
2018年 | 3411篇 |
2017年 | 2051篇 |
2016年 | 1981篇 |
2015年 | 2254篇 |
2014年 | 2478篇 |
2013年 | 3972篇 |
2012年 | 6769篇 |
2011年 | 6849篇 |
2010年 | 3512篇 |
2009年 | 2553篇 |
2008年 | 5681篇 |
2007年 | 5947篇 |
2006年 | 5739篇 |
2005年 | 5781篇 |
2004年 | 5310篇 |
2003年 | 4911篇 |
2002年 | 4676篇 |
2001年 | 3168篇 |
2000年 | 3354篇 |
1999年 | 2679篇 |
1998年 | 495篇 |
1996年 | 349篇 |
1992年 | 1268篇 |
1991年 | 1170篇 |
1990年 | 1091篇 |
1989年 | 979篇 |
1988年 | 891篇 |
1987年 | 895篇 |
1986年 | 837篇 |
1985年 | 795篇 |
1984年 | 589篇 |
1983年 | 467篇 |
1979年 | 597篇 |
1978年 | 345篇 |
1976年 | 323篇 |
1975年 | 349篇 |
1974年 | 533篇 |
1973年 | 497篇 |
1972年 | 434篇 |
1971年 | 394篇 |
1970年 | 467篇 |
1969年 | 427篇 |
1968年 | 407篇 |
1967年 | 370篇 |
1966年 | 317篇 |
Introduction
The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.Objective
To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.Methods
Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.Results
A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.Conclusion
Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality. 相似文献Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR?=?8.38), use of midazolam (OR?=?7.96), furosemide (OR?=?5.87) and vancomycin (OR?=?4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.
相似文献Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.
Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA. 相似文献